TY - JOUR
T1 - Home-based telemanagement in chronic heart failure
T2 - An 8-year single-site experience
AU - Giordano, Amerigo
AU - Zanelli, Emanuela
AU - Scalvini, Simonetta
PY - 2011/10
Y1 - 2011/10
N2 - During an eight-year period, 358 patients with chronic heart failure (CHF) were enrolled in a six-month home-based telemanagement (HBT) programme. The efficacy of the programme was evaluated in two four-year periods, based on changes in clinical, functional, Quality of Life (QoL) status and rate of hospital readmission. The New York Heart Association (NYHA) class and the number of patients with comorbidities increased significantly in the second period, while the number of patients with beta-blockers decreased significantly (P<0.01). Following the HBT programme, non-cardiovascular hospital readmission rate and all-cause readmission rate increased by 11% (P<0.03) and 13% (P<0.05), respectively. On re-evaluation after six months (238 patients) therewas a general improvement in clinical, functional and QoL status and a significant increase in the mean daily dosage of beta-blockers prescribed. Our experience confirms that HBT for patients with CHF is associated with favourable effects on hospital readmission for cardiovascular reasons and on QoL. However, a more comprehensive multidisciplinary approach will probably be required to obtain favourable effects on total morbidity.
AB - During an eight-year period, 358 patients with chronic heart failure (CHF) were enrolled in a six-month home-based telemanagement (HBT) programme. The efficacy of the programme was evaluated in two four-year periods, based on changes in clinical, functional, Quality of Life (QoL) status and rate of hospital readmission. The New York Heart Association (NYHA) class and the number of patients with comorbidities increased significantly in the second period, while the number of patients with beta-blockers decreased significantly (P<0.01). Following the HBT programme, non-cardiovascular hospital readmission rate and all-cause readmission rate increased by 11% (P<0.03) and 13% (P<0.05), respectively. On re-evaluation after six months (238 patients) therewas a general improvement in clinical, functional and QoL status and a significant increase in the mean daily dosage of beta-blockers prescribed. Our experience confirms that HBT for patients with CHF is associated with favourable effects on hospital readmission for cardiovascular reasons and on QoL. However, a more comprehensive multidisciplinary approach will probably be required to obtain favourable effects on total morbidity.
UR - http://www.scopus.com/inward/record.url?scp=80053634366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053634366&partnerID=8YFLogxK
U2 - 10.1258/jtt.2011.110201
DO - 10.1258/jtt.2011.110201
M3 - Article
C2 - 21979603
AN - SCOPUS:80053634366
SN - 1357-633X
VL - 17
SP - 382
EP - 386
JO - Journal of Telemedicine and Telecare
JF - Journal of Telemedicine and Telecare
IS - 7
ER -